TCMD - NASDAQ
Tactile Systems Technology, Inc.
$25.23
+3.4%Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
At a Glance
Live Snapshottcmd
Total Assets
Last Annual Value
273.94M
3-Year CAGR
2%
5-Year CAGR
9%
10-Year CAGR
22%
Tactile Systems Technology, Inc. Competitors Analysis of Total Assets
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Tactile Systems Technology, Inc. NASDAQ:TCMD | 273.94M | -0.9% | 2.3% | 14.0% | |
 Surmodics, Inc. NASDAQ:SRDX | 178.56M | -1.3% | -1.7% | 3.0% | |
 Delcath Systems, Inc. NASDAQ:DCTH | 123.63M | 47.4% | 30.1% | 13.4% | |
 NeuroPace, Inc. NASDAQ:NPCE | 105.56M | -0.7% | -4.6% | N/A | |
 CeriBell, Inc. NASDAQ:CBLL | 195.80M | 49.2% | N/A | N/A | |
 OrthoPediatrics Corp. NASDAQ:KIDS | 508.63M | 5.1% | 10.5% | 32.4% | |
 Viemed Healthcare, Inc. NASDAQ:VMD | 214.94M | 11.5% | 12.7% | 24.2% | |
 Semler Scientific, Inc. NASDAQ:SMLR | 239.83M | 45.4% | 36.5% | 54.6% | |
 Butterfly Network, Inc. NYSE:BFLY | 296.53M | -0.9% | -12.3% | N/A | |
 RxSight, Inc. NASDAQ:RXST | 311.81M | 19.5% | 10.1% | N/A |
Tactile Systems Technology, Inc. Fair Value Envelope
Related Guides
Continue your TCMD research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.